SIETES :: 92793 citas

Resultados de la búsqueda por DRUG UTILIZATION REFINAR BÚSQUEDA

1.

Reeve E, Low L-F, Hilmer SN. Attitudes of older adults and caregivers in Australia toward deprescribing. J Am Geriatr Soc 2019;67:junio. [Ref.ID 103159]

2.

Tracy DK. Gabapentinoids linked to new risks, including suicidal behaviour. BMJ 2019;365:12 de junio. [Ref.ID 103153]

3.

4.

Schiek S, Hildebrandt K, Zube O, Bertsche T. Fall-risk-increasing adverse reactions - is there value in easily accessible drug information? A case-control study. Eur J Clin Pharmacol 2019;75:junio. [Ref.ID 103137]

5.

Thiels CA, Habermann EB, Heffery MM. Chronic use of tramadol after acute pain episode: cohort study. BMJ 2019;365:14 de mayo. [Ref.ID 103126]

6.

Pescador D. La terrible realidad de los esteroides anabolizantes. eldiario.es 2019:11 de mayo. [Ref.ID 103107]

7.

Hedenmalm K, Slattery J, Skibicka-Stepien I, Kurz X, Morales D. Prescribing patterns of tramadol in adults in IMS® primary care databases in France and Germany between 1 January 2006 and 30 June 2016. Eur J Clin Pharmacol 2019;75:5. [Ref.ID 103092]

8.

Iacobucci G. NHS prescribed record number of antidepressants last year. BMJ 2019;364:29 de marzo. [Ref.ID 103088]

9.

Moore N, Duret S, Grolleau A, Lassalle R, Barbet V, Duong M, Thurin N, Droz-Perroteau C, Gulmez SE. Previous drug exposure in patients hospitalised for acute liver injury: a case-population study in the French National Healthcare Data System. Drug Saf 2019;42:abril. [Ref.ID 103083]

10.

Torjesen I. Pregabalin and gabapentin: what impact will reclassification have on doctors and patients?. BMJ 2019;364:11 de marzo. [Ref.ID 103081]

11.

Goodman CW, Brett AS. A clinical overview of off-label use of gabapentinoid drugs. JAMA Intern Med 2019;179:mayo. [Ref.ID 103073]

12.

Brownlee S, Garber J. Overprescribed: High cost isn’t America’s only drug problem. STAT Daily Recap 2019:2 de abril. [Ref.ID 103070]

13.

Monte AA, Shelton SK, Mills E, Saben J, Hopkinson A, Sonn B, Devivo M, Chang T, Fox J, Brevik C, Williamson K, Abbott D. Acute illness associated with cannabis use, by route of exposure: an observational study. Ann Intern Med 2019:26 de marzo. [Ref.ID 103069]

14.

Pinto T. Los nuevos anticoagulantes obligan a las farmacéuticas a pagar cientos de millones para evitar juicios . eldiario.es 2019:31 de marzo. [Ref.ID 103065]

15.

Parthipan A, Banerjee I, Humphreys K, Asch SM, Curtin C, Carroll I, Hernandez-Boussard T. Predicting inadequate postoperative pain management in depressed patients: a machine learning approach. PLoS One 2019;14:6 de febrero. [Ref.ID 103058]

16.

Zeng C, Dubreuil M, LaRochelle MR, Lu N, Wei J, Choi HK, Lei G, Zhang Y. Association of tramadol with all-cause mortality among patients with osteoarthritis. JAMA 2019;321:12 de marzo. [Ref.ID 103057]

17.

Beall RF, Hwang TJ, Kesselheim AS. Major events in the life course of new drugs, 2000–2016. N Engl J Med 2019;380:14 de marzo. [Ref.ID 103056]

18.

Chua K-P, Fischer MA, Linder JA. Appropriateness of outpatient antibiotic prescribing among privately insured US patients: ICD-10-CM based cross sectional study. BMJ 2019;364:16 de enero. [Ref.ID 103048]

19.

Alexander M. Los calmantes opioides no funcionan para el dolor crónico. ¿Por qué los seguimos recetando?. eldiario.es 2019:27 de enero. [Ref.ID 103017]

20.

Hadland SE, Rivera-Aguirre A, Marshall BDL, Cerdá M. Association of pharmaceutical industry marketing of opioid products with mortality from opioid-related overdoses. JAMA Network Open 2019;2:18 de enero. [Ref.ID 103009]